tirzepatide surmount 2 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Clinical Trial Talks: Surmount 2

Semaglutide discontinuation data from the STEP 1 extension study showed approximately two-thirds of lost weight was regained within one year of stopping treatment

Alluvi Healthcare Trusted Pharmaceutical Support Alluvi Healthcare is committed to delivering safe, high-quality pharmaceutical weight-loss treatments across the UK

Brands like Wegovy, specifically for weight management, and Ozempic, primarily for type 2 diabetes, offer different modalities, including the newly approved Wegovy pill

Uno o ms ciclos repetidos de corticoesteroides se asociaron con una reduccin de la enfermedad pulmonar severa (riesgo relativo [RR]: 0,60, intervalo de confianza [IC] del 95%: 0,48 a 0,75)